ABC Is Still Looking Good...

Citigroup has published a research report on AmerisourceBergen Corporation ABC after the company beat 3Q estimates by $0.02 and reported higher revenues than expected. In the report, Citigroup writes "ABC on Nov. 2nd bmo reported F4Q10 $0.50 vs. $0.48 Us/Cons. Co. also beat on the top line with $19.72bn vs. $19.65bn Us/$19.60bn Cons, and raised FY11 (Sept. end) EPS guidance to $2.31 to $2.41 from $2.28 to $2.36 (vs. pre-earnings $2.35 cons), +7% to 12% over FY10. We think the quarter was a ‘clean' beat and are pleased with a modest raise to guidance after a very successful year of 28% EPS growth impacted by generic Eloxatin. We raise our FY11E-FY14E EPS & continue to like the stock on strong execution, favorable macro trends, & reasonable valuation 13x fwd earnings with a relatively low risk profile. Additional share repurchases & further operating leverage offer further upside." Citigroup maintains its Buy rating and $38 price target. AmerisourceBergen closed yesterday at $31.95.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorAnalyst RatingsamerisourcebergenCitigroupHealth CareHealth Care Distributors
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!